Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2008 Jul 23.
Published in final edited form as: Int J Med Microbiol. 2006 Jun 6;296(6):405–420. doi: 10.1016/j.ijmm.2006.03.003

Inactivation of the phospholipase B gene PLB5 in wild-type Candida albicans reduces cell-associated phospholipase A2 activity and attenuates virulence

Stephanie Theiss a,b, Ganchimeg Ishdorj c, Audrey Brenot d, Marianne Kretschmar e, Chung-Yu Lan d,f, Thomas Nichterlein e, Jörg Hacker g, Santosh Nigam c, Nina Agabian d, Gerwald A Köhler a,d,*
PMCID: PMC2481510  NIHMSID: NIHMS52367  PMID: 16759910

Abstract

Phospholipases are critical for modification and redistribution of lipid substrates, membrane remodeling and microbial virulence. Among the many different classes of phospholipases, fungal phospholipase B (Plb) proteins show the broadest range of substrate specificity and hydrolytic activity, hydrolyzing acyl ester bonds in phospholipids and lysophospholipids and further catalyzing lysophospholipase-transacylase reactions. The genome of the opportunistic fungal pathogen Candida albicans encodes a PLB multigene family with five putative members; we present the first characterization of this group of potential virulence determinants. CaPLB5, the third member of this multigene family characterized herein is a putative secretory protein with a predicted GPI-anchor attachment site. Real-time RT-PCR gene expression analysis of CaPLB5 and the additional CaPLB gene family members revealed that filamentous growth and physiologically relevant environmental conditions are associated with increased phospholipase B gene activity. The phenotypes expressed by null mutant and revertant strains of CaPLB5 indicate that this lipid hydrolase plays an important role for cell-associated phospholipase A2 activity and in vivo organ colonization.

Keywords: GPI anchor, Phospholipase, Lysophospholipase, Candida, Selection marker, Virulence

Introduction

Phospholipases play a central role in cellular processes such as signal transduction and inflammation through their effect on the metabolism of phospholipids and lysophospholipids. Microbial phospholipases further contribute to pathogenesis and virulence through the release or breakdown of bioactive compounds which affect host cell function (Ghannoum, 2000; Schmiel and Miller, 1999; Songer, 1997; Titball, 1993). Substrates for phospholipases are either phospholipids or lysophospholipids, comprised of a polar head group (e.g. ethanolamine, choline, inositol, or serine esterified to phosphoric acid) and one or two non-polar fatty acyl chains esterified to a glycerol backbone. The substrate specificity of phospholipases is determined both by the phospho-headgroups and the chain length and saturation of the fatty acyl side chains. Some phospholipases have broader substrate specificities than others. Phospholipases A1 and A2 hydrolyze the ester bonds at the sn-1 and sn-2 positions of the glycerol moiety, respectively, yielding free fatty acids and 2-acyl or 1-acyl lysophospholipids. The two phosphodiester bonds found in the polar headgroup of the amphipathic phospholipid are cleaved by phospholipase C (first bond), which releases the phospho-head group, and phospholipase D (second bond) which releases only the head group. Phospholipase B enzymes possess hydrolytic activities that release both fatty acids from a phospholipid or the remaining fatty acid from a lysophospholipid (lysophospholipase). Additionally, lysophospholipase-transacylase activity is associated with some phospholipase B enzymes allowing these to transfer a free fatty acid to a lysophospholipid and hence produce a phospholipid. Hydrolase and acyltransferase activities have been detected in several fungi including Saccharomyces cerevisiae, Candida albicans, Penicillium chrysogenum, and Cryptococcus neoformans (Chen et al., 1997; Lee et al., 1994; Mirbod et al., 1995; Saito et al., 1991; Witt et al., 1984).

C. albicans, the most important fungal opportunistic pathogen (Edmond et al., 1999; Odds, 1988), harbors several phospholipase genes, including genes for phospholipases C and D as well as a gene family with homology to phospholipase B proteins (see Table 1). Although the distinction between phospholipase A, phospholipase B and lysophospholipases is difficult, clear sequence homologues of mammalian or bacterial phospholipase A1 and A2 genes seem to be lacking from the genomic repertoire of C. albicans. Two phospholipase B genes, CaPLB1 and CaPLB2, have been studied in detail (Hoover et al., 1998; Leidich et al., 1998; Mukherjee et al., 2001; Sugiyama et al., 1999); both encode putative secreted proteins with typical signal sequences, but only CaPLB1 has been clearly implicated in virulence. Abrogation of CaPlb1 activity by gene inactivation renders the mutant strain less virulent in experimental animal models (Leidich et al., 1998; Mukherjee et al., 2001). Attack of host cell membranes during tissue invasion and facilitation of adhesion processes through interaction with host-cell phospholipids (Prakobphol et al., 1994, 1997) could be crucial roles for phospholipase B enzymes in pathogenesis of C. albicans.

Table 1.

The PLB gene family in the genome sequence of Candida albicans.

Gene and reference Haploid Assembly 6 ORF(s) Diploid Assembly 19 allele(s)
CaPLB1 (Hoover et al., 1998; Leidich et al., 1998) 6.3690 19.689 / 19.8307
CaPLB2 (Sugiyama et al., 1999) 6.1985 19.690 / 19.8309
CaPLB3 (continuous allele this work) 6.795 – 6.796 19.1442 – 19.1443 / 19.9017 – 19.9018
CaPLB4 6.6206 19.6594
CaPLB5 (this work) 6.4037, 6.6348 19.5102 / 19.12568

Direct sequencing of the region between the discontinuous ORFs of CaPLB3 encoding NH2- and COOH-terminal portions of the protein revealed a continuous CaPLB3 allele (see text). ORF 6.6348 is an NH2-terminal fragment of ORF 6.4037. See also http://www-sequence.stanford.edu/group/candida/index.html, http://www.candidagenome.org/ and references (Braun et al., 2005; Jones et al., 2004)

In this study, we report the characterization of a third member of the phospholipase B gene family of C. albicans, CaPLB5, so designated due to its phylogenetic relationships (see below) with the other phospholipases. Gene expression analysis of the CaPLB gene family using relative quantitations by real-time RT-PCR revealed differential expression profiles with increased CaPLB gene expression under conditions promoting hyphal or pseudohyphal growth. Direct sequencing and sequence analysis of single CaPLB5 alleles revealed the presence of two different alleles in several strains of this pathogen. Targeted gene disruption of both alleles in a wild-type strain of C. albicans results in reduced phospholipase A2 activity in vitro and attenuated virulence as measured by host tissue colonization in a mouse model of systemic infection. Reintroduction of an intact gene copy into the null strain at the original locus results in intermediate levels of organ tissue burden when compared to the wild type and the null mutant.

Materials and methods

Microorganisms, plasmids, and culture media

The Candida albicans strains used in this work are listed in Table 2. C. albicans strain SS is a clinical isolate provided by Dr. Remo Morelli (San Francisco State University, San Francisco, CA). The Ura- auxotrophic strain C. albicans CAI4 was provided by Dr. W. Fonzi (Department of Microbiology and Immunology, Georgetown University Medicine Center, Washington, DC). The wild-type strain C. albicans ATCC 44808 was used for gene disruptions (see below). C. albicans cells were propagated on YPD agar plates (10 g yeast extract, 20 g peptone, 20 g glucose, 15 g agar per liter) or YPD medium at 30°C. Lee's medium was used to grow C. albicans in yeast or filamentous forms (Lee et al., 1975). Host for subcloning and sequencing in pBluescript was Escherichia coli DH5α. For screening of the genomic library of C. albicans in Lambda FixII (Stratagene, La Jolla, CA) E. coli XL1-Blue MRA (P2) was used. Bacteria were grown at 37°C in Luria-Bertani (LB) medium with suitable supplements.

Table 2.

Genotypes of C. albicans strains used in this study

Strain Parent and genotype Source or reference
SS clinical isolate Miyasaki et al., 1994
SC5314 wild-type strain Gillum et al., 1984
CAI4 SC5314; ura3Δ::λimm434/ura3Δ::λimm434 Fonzi and Irwin, 1993
ATCC 44808 wild-type strain isolated from human blood Manning and Mitchell, 1980
KH44 ATCC 44808; plb5LKΔ::FRT-FLP-MPAR-FRT/PLB5SN This work
KH44-13 KH44; plb5LKΔ::FRT/PLB5SN This work
KH44-90 KH44-13; plb5LKΔ::FRT/plb5SNΔ::FRT-FLP-MPAR-FRT This work
KH44-91 KH44-90; plb5LKΔ::FRT/plb5SNΔ::FRT This work
KH44-KI KH44-91; plb5LKΔ::FRT/PLB5LK-FRT-FLP-MPAR-FRT This work
KH44-KL KH44-KI; plb5LKΔ::FRT/PLB5LK-FRT This work

Cloning and sequencing of CaPLB5

Mapping and sequencing of a 10-kb PstI-PstI genomic DNA fragment, encoding almost the entire ABC transporter gene MLT1 (Theiss et al., 2002), revealed an incomplete ORF with high similarity to fungal phospholipases. The entire coding region of the putative phospholipase B gene CaPLB5 was isolated from a C. albicans fosmid library (kindly provided by Dr. S. Scherer) using probes derived from the known sequences of the phospholipase and MLT1 respectively. Fosmid clone 9d6 was further sequenced by primer walking. Using the oligonucleotide primers AMPLI1 (for oligonucleotide sequences, see Table 3) and AMPLI3 the entire CaPLB5 gene with 1 kb 5′-flanking region and 0.4 kb 3′-flanking region was PCR amplified from several C. albicans strains and sequenced with the dideoxy sequencing method using a Thermo Sequenase Fluorescent Labeled Primer Cycle Sequencing Kit (Amersham Pharmacia Biotech) and a LI-COR DNA Sequencer 4000 (Lincoln, NE). The nucleotide sequence of CaPLB5 was submitted to GenBank under the accession number AF038128.

Table 3.

DNA oligonucleotides used in this study

Oligonucleotide 5′-Sequenz-3′
AMPLI1 TAGTCAAGCTTCGCCATTACAAAGAGC
AMPLI3 CTACTAAGCTTTTCCACTGGTGCATC
AMPLI6 CTACTACTAGTGTCGACGTTTTCCACTGGTGCATC
DTNOT AATTCGCGGCCGCTTTTTTTTTTTTTTTT
ECOMUPL3 TAGTCGAATTCTTGCTGAGATAG
NOTTAG TAATTGCGGCCGCTGCAGNWNNSNCTCAGTAACAGATACTTG
P3_1340 TATCGTGCCATGCTTAATGG
P3_2305 CCAATCCCGCCATCTATAAC
PLB1390 GACTGCTCGAGTGTAGAACTTGCTGAATCG
RACE3 CAGATGTAAGTGACGAGG
UPPLIP3 TCCACCACTGAATGACAACC
XNTAG CAGGGACGACTGCTCGAGNRNNRNTGTAGAACTTGCTGAATCG
PLB1-A GATGAATGGGCAGCATGTGTT
PLB1-B GGCTCACCCTTATAGATGGTACCA
PLB1-D GCATCTCTTACATTGTTCTGTCTGTTC
PLB1-E (Probe) TCTTTCTTGCTCTCTCCGTATGATGGCG
PLB2-A AGGTGAAGACGGTCAGAATGTTC
PLB2-B GCTGATCCATCTGGCCAATT
PLB2-C ATGTTCCCTTGCTTCCATTGA
PLB2-D TGTTTTTATCTGCCGATTGATCA
PLB2-E (Probe) CCACCGTAAGGTAAGCGCAATCTTTGC
PLB3-A AAGAAAGACGTGGTATTGAACAACTG
PLB3-B TGCTTCCATTAGTTAAACTTGAATCAG
PLB3-C TGGTATTGAACAACTGGATCAATGT
PLB3-E (Probe) AAGTACCATCCCAACAATAATT
PLB4-A TCGCTTATGATAATTCGGCTGATA
PLB4-B CCACATCAGGTACATATGGGAAACT
PLB4-C TGCCTCCATGGTAGCATCATAC
PLB4-E (Probe) ATTTGGGAATCAAAGTAATGG
PLB5-A CGCTGCCTCTGTCTCTAGTGTTAG
PLB5-B GATGATCCGGTAGTGGTACTGGTT
PLB5-C CTTGCAGCTAAAACCCACACAA
PLB5-D GATCCGGTAGTGGTACTGGTTTG
PLB5-E (Probe) TGGCGGTACATCTTCCACGACCCA

Restriction enzyme sites are underlined and sequence tags are in bold. Oligonucleotides for nested and semi-nested real-time PCR are italicized.

Nucleic acid isolation and hybridization

Genomic DNA for cloning and Southern hybridizations was isolated from C. albicans as described previously (Millon et al., 1994). Southern hybridizations were carried out with non-radioactive probes using the ECL labeling and detection kit (Amersham Pharmacia Biotech, Freiburg, Germany). A PCR fragment generated with primer pair AMPLI1/PLB1390 was used as probe for CaPLB5 hybridizations. Total RNA for Northern hybridizations was isolated with the hot acid phenol method (Ausubel et al., 1989). Membrane-bound RNA was stained with methylene blue before hybridization to check rRNA bands for equal loading. Hybridizations were carried out using standard protocols.

Messenger RNA mapping

The start points of CaPLB5 transcription were determined by 5′-RACE (Ausubel et al., 1989). Following reverse transcription with Superscript II (Stratagene) of total RNA with the CaPLB5-specific primer UPPLIP3, a poly A tail was added to the first strand by terminal deoxynucleotide transferase action. Subsequently, the 5′-end of the CaPLB5 cDNA was amplified with the anchor primer DTNOT and the nested primer ECOMUPL5. PCR fragments were cloned in pBluescript after digestion with NotI and EcoRI, and four clones were sequenced. The polyadenylation sites of CaPLB5 mRNA were identified by 3′-RACE: Following the isolation of poly A+ RNA from total RNA using a Oligotex mRNA Mini Kit (Qiagen, Hilden, Germany) the RNAs were reverse transcribed using primer DTNOT. The 3′-end of the CaPLB5 cDNA was amplified with primers RACE3/DTNOT, subsequently cloned and sequenced.

Targeted disruption of the C. albicans CaPLB5 gene

Sequence-tagged disruption cassettes consisting of the dominant selection marker MPAR (Köhler et al., 1997; Theiss et al., 2002), the inducible site-specific recombinase caFLP (Staib et al., 1999; Wirsching et al., 2000) and CaPLB5-specific flanking regions were constructed for gene disruption (see Fig. 4). Initially, a PCR fragment generated with primers AMPLI1 and AMPLI3 from genomic DNA of strain ATCC 44808 was cut with HindIII at the site introduced by AMPLI1 and with BamHI at an internal site in CaPLB5. This fragment was cloned in pSKK (pBluescript SK with the KpnI site removed) to yield pKP1. Removal of the NotI and XhoI sites in pKP1 resulted in pKPNX25. The product of the divergent PCR of pKPNX25 with the primers XNTAG and NOTTAG was cut with XhoI and NotI and subsequently ligated to the XhoI-NotI fragment of pSFI1 (Wirsching et al., 2000) harboring the MPAR flipper. Following transformation in E. coli, bacterial clones carrying plasmids were pooled, their bar-coded plasmids were isolated (pDIS-Pool) and digested with ApaI/SacI to yield the linear disruption constructs. Gel-purified DNA fragments were used for transformation of C. albicans ATCC 44808 by electroporation as described previously (Köhler et al., 1997). Transformants were plated on SC medium (6.7 g YNB, 0.77 g Complete Supplement Mixture (Bio 101), 20 g glucose, and 15 g agar per liter) containing 10 μg/ml mycophenolic acid (MPA; Sigma-Aldrich). Positive clones were screened for correct integration of the disruption cassette by PCR and Southern hybridization. Excision of the MPAR flipper necessary for sequential disruption of both CaPLB5 alleles was carried out as described previously (Morschhäuser et al., 2005; Wirsching et al., 2000). Amplicons spanning the tagged integration sites of homozygous disruption mutants were generated and sequenced directly. For confirmation of the expected recombinations on both homologous chromosomes, the four sequence tags flanking the integration sites had to be different.

Fig. 4.

Fig. 4

CaPLB5 disruption and reintegration. (A) Schematic diagram of a CaPLB5 disruption cassette with random sequence tags depicted as „N“ (not drawn to scale, tags omitted from subsequent diagrams). Two cassettes with different tags were used sequentially to inactivate the CaPLB5 gene. Heterozygosity of the tags present on both alleles could be easily detected by direct sequencing of PCR products across the integration site. Using the MPAR flipper strategy, each integration step was followed by FLP recombinase-mediated excision of the dominant MPAR marker leaving only a FRT (shown as black triangle) sequence flanked by tags. (B) Construct used for reintegration of an intact CaPLB5 allele in the caplb5/caplb5 mutant KH44-91. (C) Southern hybridization analysis of genomic DNA (ScaI digest) isolated from the wild type ATCC 44808, the heterozygous mutants KH44 and KH44-13, the null mutants KH44-90 and KH44-91 as well as strain KH44-KL with a reconstituted CaPLB5 allele. Diagrams of the hybridization fragments are shown on the right. Additionally, Northern hybridization results of total RNAs isolated from the aforementioned strains are shown. The null mutants showed no CaPLB5 expression, the heterozygous strains and the complemented strain showed reduced levels of expression when compared to the wild type. Methylene blue staining of membrane-bound rRNAs served as loading control. The location of the probe used in Northern and Southern hybridizations is indicated with a black line. B (BamHI), K (KpnI), P (PstI), Sc (ScaI).

Reintegration of CaPLB5 in a caplb5 null mutant

For complementation of the caplb5/caplb5 null mutation, an insertion construct with an intact CaPLB5 gene copy was generated. For this purpose, a PCR amplicon harboring the CaPLB5 gene and its promoter/terminator regions was generated with primers AMPLI1 and AMPLI6 and subsequently digested with SpeI/HindIII. This fragment was ligated to the SpeI-HindIII plasmid backbone of a derivative of pKPNX25 without the SalI site in the multiple cloning site, thereby substituting the insertion cloned in pKPNX25 (see above) with a functional CaPLB5 gene plus flanking regions. The resulting plasmid was named p4486. The XhoI-SacII fragment of one disruption plasmid of pDIS-Pool comprised of the MPAR-flipper and a 3′-fragment of PLB5 was inserted in p4486 that had been digested with SalI/SacII (the SalI site was introduced by primer AMPLI6), resulting in pPIKOM. The ApaI-SacI fragment of pPIKOM containing the CaPLB5-MPAR–Flip-3′-Δcaplb5 construct was used for transformation of the null mutant C. albicans KH44-91. Transformants were screened by PCR for reintegration of CaPLB5 at one of the disrupted loci. One transformant (KH44-KI) was chosen for MPAR flipper removal and the resulting MPA-sensitive strain KH44-KL was used as the CaPLB5 complementation control.

Growth characteristics of caplb5 mutants in culture

Growth of mutated strains was compared to wild-type growth in liquid media and agar plates of YPD, SC, RPMI1640, Lee's media and 10% fetal calf serum at 25, 30 and 37°C. Growth and filamentation was also tested on Synthetic Low Ammonium Dextrose (SLAD; (Csank et al., 1998)) agar plates following incubation at 37°C for 7 days. Furthermore, Sabouraud Dextrose Agar, YPD and Lee's pH 6.8 media plates were also supplemented with 10% egg yolk to detect secretion of lipolytic compounds around colonies. Growth in the presence of lysophosphatidylcholine (Lyso-PC; Sigma-Aldrich) or lysophosphatidylinositol (Lyso-PI; Avanti Polar Lipids, Alabaster, AL) was determined by OD600 measurement after 24 and 48 h incubation of cultures in 5-ml glass tubes at 30°C.

Determination of phospholipase A2 (PLA2) activity

PLA2 assays were performed as described earlier (Chaitidis et al., 1998). Briefly, 25 μM of 1-palmitoyl-2-arachidonoyl phosphatidylcholine (PAPC) was sonicated for 1 min in assay medium containing 10 mM Tris-HCl, pH 8.0, 150 mM NaCl and 5 mM CaCl2. Following preincubation for 5 minutes, the reaction was started with 50 μg of cell lysate from the wild-type C. albicans strain ATCC 44808 or the CaPLB5 mutants, which were grown in Sabouraud glucose broth containing 1% peptone medium for 36 hours at 37°C. After a reaction time of 15 min lipids were extracted from the mixture by the Bligh and Dyer method (Bligh and Dyer, 1959). Liberation of arachidonic acid (AA) was measured by reverse-phase HPLC on a Nucleosil-100-7 C18 column (Macherey-Nagel, Germany) with a precolumn 5-C18-AB using a solvent system with methanol:water:acetic acid (85:15:0.01, v/v) at a flow rate of 1 ml/min. Detection was performed with a Diode Array Detector (Shimadzu, Japan). Peaks eluted at about 11.8 min represented AA and were quantitated by peak area using a calibration curve with authentic cPLA2, sPLA2, and iPLA2 standards.

Systemic infection model with CaPLB5 mutants

Balb/c mice were infected via the tail vein with 0.4 ml of a 0.9% NaCl solution containing 4 × 105 cells of either the wild-type strain C. albicans ATCC 44808, the heterozygous caplb5/CaPLB5 mutant KH44-13, the null mutant KH44-91 or the complemented strain KH44-KL. Mice were sacrificed after 3 days post inoculation, and colony-forming units (CFU) of C. albicans were determined after homogenization of isolated organs.

Multiplex real-time RT-PCR expression analysis

Strain ATCC 44808 was grown to stationary phase in Lee's medium pH 6.8 at 25°C, washed two times, subsequently inoculated in fresh Lee's medium pH 4.5 and pH 6.8, respectively. Cultures were incubated in a rotary shaker at 25°C or 37°C for 3 h and 48 h. Total RNA was isolated using glass bead disruption and TRIZOL reagent (Invitrogen, Carlsbad, CA). Following DNase I treatment total RNA was further purified with RNeasy (Qiagen). The RT nested or semi-nested real-time PCR was carried out as previously described (Dolganov et al., 2001) with few modifications. A 10-ng aliquot of DNase-treated total C. albicans RNA was reverse transcribed using SuperScriptIII First-Strand Synthesis System (Invitrogen) and oligo (dT)20 primers. One-tenth of the cDNA was pre-amplified using the Advantage 2 Polymerase Mix (BD Biosciences Clontech, Palo Alto, CA) with a mixture of the respective outer primers A and B (see Table 3). The multiplexed PCR reactions were performed with 1 cycle at 94°C for 1 min; 25 cycles at 94°C for 15 s, 55°C for 15 s, 70°C for 15 s; and 1 cycle at 70°C for 5 min in a PTC-200 Peltier Thermal Cycler (MJ Research, South San Francisco, CA). For the real-time PCR reactions, 3 μl of 1:60 diluted pre-amplification material was added to a total 10-μl real-time PCR mix containing QuantiProbe PCR Master Mix (Qiagen, Valencia, CA), a 6-FAM and BHQ-1 labeled probe (primer E), inner primers C and D for CaPLB2 and CaPLB5 genes or primers C and B for CaPLB3 and CaPLB4 genes. For CaPLB1 the primer combination was A, D, and E. The real-time PCR reactions were performed with 1 cycle at 50°C for 2 min; 1 cycle at 95°C for 10 min; and 40 cycles at 95°C for 15 s and 60°C for 1 min in an ABI 7900HT Sequence Detection System (Applied Biosystems, Foster City, CA). All the primers and probes were designed using Primer Express software (Applied Biosystems) and were synthesized by Biosearch Technologies (Novato, CA). The cycle at which the amplification product signal reached a threshold (the threshold cycle, CT value) was analyzed using SDS2.1 software following the manufacturer's instructions (Applied Biosystems). The threshold was chosen within the geometric (exponential) phase of the amplification curve. To choose a robustly expressed control gene, the CT values of ∼90 genes obtained from cells grown at 7 different growth conditions were compared using the GeNorm software (www.wzw.tum.de/gene-quantification/). EFB1 was stably expressed in this analysis and was used for data normalization. An average CT value was obtained from the three data sets and normalized to the average CT value of EFB1. For relative quantitation of gene expression, the comparative CT method was used (Applied Biosystems, 2001) and relative expression was determined as 2-ΔΔCT.

Results

The CaPLB5 gene from Candida albicans: sequence, annotation and characterization

CaPLB5, isolated as described in Materials and methods, lies in close proximity to a 5′-ORF with deduced amino acid sequence similarity to phosphomutases (CaPMU5, allelic orfs 19.5103 and 19.12569 in Assembly 19 of the C. albicans genome sequence) and a 3′ ORF 6.4036 (19.5101 and 19.12567) that is located downstream of CaPLB5 on the opposite DNA strand encoding a candidal homologue of the S. cerevisiae CCR4 gene (see Fig. 1A).

Fig. 1.

Fig. 1

Fig. 1

Gene organization at the CaPLB5-MLT1 locus and primary structure of CaPLB5. (A) Schematic representation of the CaPLB5 locus with the adjacent genes CaCCR4 and MLT1 as well as the partial ORFs CaPMU5 and CaNTG1. (B) Nucleotide sequence of one allele of CaPLB5 in C. albicans ATCC 44808 and its deduced amino acid sequence. The stop codons of the adjacent genes CaPMU5 and CaCCR4 are boxed in the promoter and terminator region, respectively. Putative TATA elements in the promoter region are underlined. Transcription start sites are marked by an upward arrow, a polyadenylation site in the terminator is marked by a downward arrow. The sequence region deleted in the gene disruption (see Fig. 4) is underlined with a undulate line. Amino acids KR as possible Kex2p processing sites are indicated by deltas (ΔΔ). The putative NH2-terminal signal peptide and the hydrophobic COOH-terminal with a putative ω cleavage site are double underlined. The NH2-terminal serine-rich region unique to CaPlb5 is in bold italics. Non-silent allelic differences to the second allele in ATCC 44808 and to both SC5314 alleles are marked by gray shading. Highly conserved active-site regions in the protein sequence are boxed.

CaPLB5 shows the highest deduced amino acid sequence identity in databank searches with known fungal type B phospholipases (lysophospholipases); these include C. albicans CaPlb1 (identity 46%; (Hoover et al., 1998; Leidich et al., 1998; Mukherjee et al., 2001)) and CaPlb2 (47%; (Sugiyama et al., 1999)) and enzymes from S. cerevisiae (ScPlb1 46%, ScPlb2 47%, ScPlb3 48%; (Lee et al., 1994; Merkel et al., 1999)) or Penicillium chrysogenum Plb1 (42% (Masuda et al., 1991)). Pfam searches also reveal a lysophospholipase catalytic domain (Accession number: PF01735; from amino acids 177 to 670; Fig. 1B) within CaPlb5 which is found in other phospholipase B enzymes and cytoplasmic phospholipase A2.

TBlastn analysis of the C. albicans genome Assembly 19 (http://www-sequence.stanford.edu/group/candida/) with the CaPlb5 sequence revealed additional ORFs with a high degree of homology to this protein and to the other fungal Plbs (see Table 1): The protein encoded by orf19.6594 (only one allele in Assembly 19) shares 52% identity and is the most closely related protein to CaPlb5; this gene has been annotated as CaPLB4 by the C. albicans Genome Annotation Consortium (Braun et al., 2005). ORFs 19.1442/9017 and 19.1443/9018 are adjacent to each other on contigs 10119/20119 of the recent Assembly 19 of the C. albicans genome. According to their sequence similarities, they could encode the NH2-terminal and COOH-terminal portion of a fifth phospholipase B, which we denote CaPlb3 due to its closer phylogenetic relationship with CaPlb1 and CaPlb2 (see below). Since the short region separating these ORFs does not harbor canonical splice sites for an intron, we resequenced the region to check whether CaPLB3 is likely to be a pseudogene. A PCR product was generated from genomic DNA of C. albicans SC5314 using the primer pair P3_1340-P3_2305 and sequenced directly. The region between the ORFs showed no sequence ambiguities indicative of allelic differences, however, in comparison to Assembly 19 the TAA stop codon of ORFs 19.1442/9017 was replaced by TTA encoding leucine and a cytidine residue at position 24 of ORFs 19.1443/9018 was deleted leading to a frameshift that renders the respective allelic CaPLB3 ORFs continuous. For the following studies we used the deduced amino acid sequence of the corrected CaPLB3 gene.

An amino acid alignment of CaPlb5 and other fungal Plbs was carried out with CLUSTALX (Version 1.8) with default parameters and then manually corrected (data not shown). CaPlb5 shares conserved sequences reported to be essential for phospholipase activity (Ghannoum, 2000) with each of these proteins (boxed in Fig. 1B: SGGGYRAM, GLSGG and DGGEDLQN). The arginine, serine and aspartate residues in bold might constitute the active center triad of these enzymes. Due to an NH2-terminal extension that includes a serine-rich domain (amino acids 25-91) the deduced protein sequence of CaPlb5 is 754 amino acids in length, resulting in a theoretical Mr of 81,373, and considerably larger than most other known fungal Plbs. Among the completed fungal genome sequences a similar N-terminal extension is only found in a putative Plb of the hemiascomycetous yeast Debaryomyces hansenii (Dujon et al., 2004). The aligned Plb protein sequences were used to construct a phylogenetic tree with the maximum parsimony algorithm in PAUPSEARCH of the Wisconsin Package (Version 10.3; Accelrys Inc., San Diego, CA). As shown in Figure 2, candidal Plbs appear to form two subclusters together with three D. hansenii proteins in this phylogenetic tree, one cluster including CaPlb1, CaPlb2, CaPlb3 and a single D. hansenii orthologue, the other cluster the enzymes CaPlb4 and CaPlb5, each with a respective D. hansenii orthologue. Overall, the phylogenetic tree constructed with fungal Plbs correlates well with trees derived from other phylogenetic markers (e.g. rDNA; (Diezmann et al., 2004)). Nodes marking the Hemiascomycetes (yeasts), Euascomycetes (Aspergilli, etc.), Archiascomycetes (Schizosaccharomyces pombe), and Basidiomycetes (Cryptococcus and Ustilago) clearly can be found.

Fig. 2.

Fig. 2

CaPlb5 and other fungal Plbs. The unrooted phylogenetic tree was generated using the maximum parsimony algorithm in PAUPSEARCH/PAUPDISPLAY of the GCG package with aligned Plb sequences. Organism and Plb (accession number in parentheses): Aspergillus fumigatus, AfPlb1 (AAQ85122), AfPlb2 (AAQ85123); A. nidulans, AnPlb1 (EAA64795), AnPlb2 (BAD95522); C. albicans, CaPlb1 (AAC61890), CaPlb2 (BAA36162), CaPlb3 (orf19.1442/3; the continuous amino acid sequence deduced from direct sequencing of the junction between the adjacent ORFs was used), CaPlb4 (orf19.6594), CaPlb5 (AAF08980); C. glabrata, CgPlb1 (AAM16160), CgPlb2 (AAM19335), CgPlb3 (CAG58709); Cryptococcus bacillisporus, CrbPlb1 (CAC83081); Cr. neoformans, CnPlb1 (AAF65220), CnPlb2 (AAF61964); Debaryomyces hansenii, DhPlb1 (CAG88860), DhPlb2 (CAG87754), DhPlb3 (CAG90378); Gibberella zeae, GzPlb1 (EAA69595), GzPlb2 (EAA70315), GzPlb3 (EAA73343); Kluyveromyces lactis, KlPlb1 (BAA28619); Magnaporthe grisea, MgPlb1 (EAA56932); Neurospora crassa, NcPlb1 (AAC03052), NcPlb2 (CAE76554); Penicillium chrysogenum, PcPlb1 (P39457); Pichia jadinii, PjPlb1 (BAC79383); S. cerevisiae, ScPlb1 (NP_013721), ScPlb2 (NP_013719), ScPlb3 (NP_014632); Schizosaccharomyces pombe, SpPlb1 (NP_593194), SpPlb2 (CAB94277), SpPlb3 (CAB40176), SpPlb4 (CAB57433), SpPlb5 (CAB16354); Torulaspora delbrueckii, TdPlb1 (BAA06860); Ustilago maydis, UmPlb1 (EAK81777), and Yarrowia lipolytica, YlPlb1 (CAG79599). CaPlb family members are depicted in bold.

Mapping of the CaPLB5 transcript provides evidence that the translational start is likely to be the ATG designated as position 1 (Fig. 1B). Start sites of transcription were localized by 5′-RACE to positions –137 and –90, thereby confirming the ATG at position 1 as the first start codon in the CaPLB5 mRNA and concomitantly the NH2-terminal extension of CaPlb5. Putative TATA elements for promoter activity are marked in Figure 1B. Using 3′-RACE, a polyadenylation site was identified at position 2300, 39 bp from the end of the CaPLB5 coding sequence.

A putative signal peptide with a cleavage site at amino acid 19 was detected at the NH2-terminus of CaPlb5 by SIGNALP (Nielsen et al., 1997). Presence of an NH2-terminal signal peptide as well as a COOH-terminal stretch of hydrophobic amino acids suggest that CaPlb5 contains a GPI-anchor at the processed COOH-terminus (see Fig. 1B). The asparagine at position 726 was identified as a potential cleavage site ω for the COOH-terminal GPI-attachment signal peptide using the Big-PI Fungal Predictor (Eisenhaber et al., 2004) for modification site prediction. Analysis of the other Plbs in C. albicans revealed potential GPI-anchor sites in CaPlb3 and CaPlb4 (data not shown). De Groot et al. (2003) recently used another algorithm to identify fungal GPI proteins and also denoted the three CaPlbs as GPI modified, albeit with differences in the location of the ω sites. Another study only predicted CaPlb5 to be GPI anchored (Lee et al., 2003).

Heterozygosity of CaPLB5 alleles

Direct sequencing of PCR products derived from the CaPLB5 region in the homozygous strains C. albicans CAI4 and ATCC 44808 revealed nucleic acid sequence ambiguities at several positions (for details see Fig. 1B). For corroboration of these sequence variations we sequenced the single intact alleles in heterozygous caplb5 mutants. At least two distinct CaPLB5 alleles exist in each of the C. albicans strains CAI4 and 44808 with sequence variations in the gene coding sequences. Surprisingly, apart from silent mutations (data not shown) the alleles differ even in their amino acid sequence since at two positions in the CaPLB5 gene a non-silent C/T transition and a G/T transversion lead to the substitution of leucine to serine (amino acid position 57) and lysine to asparagine (amino acid position 208), respectively. Therefore, we designated one allele as L57K208 and the other as S57N208. Figure 1B compares the sequence of the S57N208 allele of strain ATCC 44808 with the L57K208 allele in the protein sequence. BLAST analysis (Altschul et al., 1990) of the recent Assembly 19 of the Candida Genome Sequencing Project (http://www-sequence.stanford.edu/group/candida/search.html) reveals that the same allelic differences in the protein sequences are also present in the CaPLB5 alleles (ORFs 19.5102/12568) of the sequenced strain C. albicans SC5314 that is the parent strain to CAI4 (Fonzi and Irwin, 1993). Besides a few silent mutations in the nucleic acid sequences (data not shown), there is only one additional amino acid exchange at position 709 between the pairs of allelic sequences of ATCC 44808 and SC5314 (see Fig. 1B). Comparison of the other CaPlb protein sequences in Assembly 19 reveals the presence of further allelic sequence differences in CaPlb1 (D577N; ORFs 19.689/8307) and the NH2-terminal fragment of CaPlb3 (S346L; ORFs 19.1442/9017).

CaPLB5 expression analysis

CaPLB5 mRNA expression during growth in YPD medium at 30°C was monitored from logarithmic to stationary phase by Northern hybridization using total RNAs isolated at various times in the growth cycle (4, 6, 8, 10, 12, 14, 16, and 24 h). The transcript was detected throughout the time course, however, its level increased about 3-fold within the 4- to 10-h period of logarithmic phase and then remained constant from late-log phase to 24 h (data not shown). To address whether CaPLB5 mRNA is regulated during the transition from yeast to hyphal cells, we isolated total RNA from C. albicans freshly inoculated from overnight cultures and grown for 3 h in Lee's media (Lee et al., 1975) favoring either growth of yeast forms (pH 4.5, 25°C) or germ tubes (pH 6.8, 37°C). Cells were also incubated at intermediate conditions of pH 6.8, 25°C and pH 4.5, 37°C. While cells grew in the yeast form at 25°C, they showed substantial pseudohyphal growth at pH 4.5, 37°C. The highest levels of CaPLB5 mRNA after 3 h incubation as determined by real-time RT-PCR were found in RNA isolated from the germ tubes grown at 37°C, pH 6.8, while the lowest levels were found in cells grown at 25°C (see Fig. 3). The other CaPLBs showed the highest expression at pH 4.5, 37°C, especially CaPLB1 with 66-fold induction., After prolonged incubation in the media for 48 h, expression levels for all CaPLBs increased to a large extent, in particular under conditions with low pH (4.5) and elevated temperature (37°C; see Fig. 3). Overall, CaPLB expression patterns became very similar. CaPLB1, CaPLB2 and CaPLB3 transcript levels are very low at 3 h in 25°C, which explains the high induction levels e.g. at 48 h, 37°C, pH 4.5. Northern hybridization results (data not shown) corroborate these results since CaPLB1 to CaPLB3 mRNAs were not detectable in RNA isolated at 3 h, 25°C.

Fig. 3.

Fig. 3

Relative quantitation of CaPLB1, CaPLB2, CaPLB3, CaPLB4 and CaPLB5 expression in Lee's medium. C. albicans ATCC 44808 cells were grown under the indicated pH and temperatures to promote yeast (pH 4.5 or pH 6.8 at 25°C), hyphal growth (pH 6.8, 37°C) or mixed growth with predominantly pseudohyphae (pH 4.5, 37°C) and total RNA was isolated after 3 h and 48 h of growth. Two-step multiplex real-time RT-PCR was performed to determine the relative expression (2-ΔΔCT) of the CaPLB genes. Expression levels of the stably expressed EFB1 gene were used for normalization as described in the Materials and methods section. Expression levels were calibrated to the respective CaPLB level in Lee's medium pH 4.5 at 25°C, 3 h. Average values and ranges (error bars) of relative expression in triplicate quantitations are shown. The predominant morphotypes for the respective growth conditions are indicated: yeast (Y), pseudohyphae (Ph), germ tubes (Gt), and hyphae (H).

Generation of CaPLB5 mutants

A caplb5/caplb5 null mutant of the wild-type strain C. albicans ATCC 44808 was generated by sequential targeted gene disruption using the dominant MPAR resistance gene in conjunction with the inducible caFLP recombinase system for marker excision (MPAR flipper; (Wirsching et al., 2000)). The heterozygous caplb5LK/CaPLB5SN mutant C. albicans KH44-13 was used in a second round of disruption to inactivate the remaining intact CaPLB5 allele finally yielding, after marker excision, the homozygous mutant KH44-91. Figure 4 shows the disruption strategy and verification by Southern hybridization of genomic DNA. The disruption cassettes included short random sequence tags flanking the FRT sites of the MPAR flipper construct which could be used to exclude mitotic recombination or chromosome loss as the cause for caplb5 homozygosity in the null mutant KH44-91 (see Materials and methods). The 638-bp deletion in each CaPLB5 allele comprised two out of three conserved domains reportedly essential for phospholipase activity (see above and Fig. 1) and resulted in loss of full-length CaPLB5 mRNA expression in the null mutants as documented by Northern analysis (Fig. 4). The heterozygous caplb5LK/CaPLB5SN mutants KH44 and KH44-13 showed similarly reduced CaPLB5 transcript levels when compared to the wild-type expression. We chose to delete only a portion of the 2262-bp coding sequence because of close proximity of the CaCCR4 gene (see Fig. 1).

For verification that the null mutant phenotype was not due to ectopic effects generated during the transformation procedure, a complemented strain with a reintegrated intact CaPLB5LK allele was constructed from KH44-91 using the MPAR flipper cassette shown in Figure 4B. Correct integration of the CaPLB5LK-MPAR flipper cassette in strain KH44-KI was verified by PCR, and the subsequent marker excision resulted in strain KH44-KL, a CaPLB5LK-FRT/caplb5LKΔ::FRT heterozygote that had regained intermediate expression of CaPLB5, similar to the expression level seen in KH44 and KH44-13 (see Fig. 4).

Phenotypic characterization of CaPLB5 mutants

Growth of wild-type C. albicans ATCC 44808, the caplb5 mutants and the reconstituted strain KH44-KL was compared in several media (YPD, Lee's, Spider medium, 10% serum, and synthetic low ammonium dextrose, SLAD (Csank et al., 1998)) and no differences in growth rate and morphology were observed. C. albicans ATCC 44808 consistently formed the largest precipitation zones around colonies on egg yolk agar (see Materials and methods) of all C. albicans strains tested (SC5314, CAI4, SS). This could indicate higher secreted lipolytic activities of ATCC 44808, however, we could detect no differences in precipitation zone formation between this wild-type strain and its isogenic caplb5 mutants on different media with egg yolk. Growth assays with addition of lyso-PC (0.1, 1, 10 mM) and lyso-PI (0.01 to 0.5 mM), both possible substrates for CaPlb5, revealed in comparison to the wild-type strain no altered susceptibility of the caplb5 null mutant to these compounds. However, release of arachidonic acid (AA) from 1-palmitoyl-2-arachidonoyl phosphatidylcholine (PAPC), as measured in a PLA2 assay of cell lysates, dropped below detection levels in the caplb5 null mutant, while the heterozygous mutant and the CaPLB5 complemented strain retained approximately half of the activity of the wild type (see Table 4). Thus the CaPLB5 alleles encode a significant portion of cell-bound PLA2 activity in C. albicans.

Table 4.

Release of arachidonic acid from 1-palmitoyl-2-arachidonoyl phosphatidylcholine (PAPC) by C. albicans lysates

Source of enzymatic activity Arachidonic acid liberation from PAPC (μM/min)
cPLA2 (0.25 IU) 2.4 ± 0.3 (5)
ATCC 44808 1.1 ± 0.2 (3)
KH44-13 0.55 ± 0.1 (3)
KH44-91 < 0.01 (3)
KH44-KL 0.73 ± 0.24 (3)

The values of arachidonic acid liberation represent the mean and ± SD of the indicated number of experiments (denoted in parentheses). Cytosolic PLA2 (cPLA2) was used as control. Experimental conditions are described in Materials and methods.

To determine whether, similar to CaPlb1 (Ghannoum, 2000; Ibrahim et al., 1995; Mirbod et al., 1995; Mukherjee et al., 2001), CaPlb5 as a putative phospholipase is involved in virulence, we compared the organ colonization of caplb5 mutants to the wild type in a mouse systemic infection model. Disruption of the CaPLB5 gene led to an attenuated virulence phenotype of the caplb5 null mutant strain KH44-91 of intravenously infected Balb/c mice. Using ANOVA and Dunett error protection CFUs in the liver and the left kidney of strain KH44-91 were identified as significantly reduced when compared to infection with the wild-type strain ATCC 44808, while in the brain as well as in the right kidney CFU reduction was statistically not significant (Fig. 5). The heterozygous mutant KH44-13 with a wild-type CaPLB5SN allele and the reconstituted strain KH44-KL with a single intact copy of CaPLB5LK showed intermediate levels of CFU. Homozygous caplb5 null mutants generated in the ura-negative strain CAI4 using the URA3-blaster technique (Fonzi and Irwin, 1993) showed similar attenuation of organ colonization in vivo (referenced to the ura3/URA3 parent C. albicans CAF2-1; data not shown). However, reported difficulties in interpretation of virulence studies that could be encountered with an auxotrophic strain (Chen et al., 2004; Garcia et al., 2001), led us to abandon the URA3-blaster strategy and instead use the above described MPAR flipper method in a wild-type strain.

Fig. 5.

Fig. 5

Organ colonization in a systemic mouse model with the mutant strains in comparison with the wild type. CFUs of infected organs were determined in four mice for each strain. ANOVA and Dunnett error protection was used to calculate statistical significance of differences in organ colonization: CFUs of the caplb5 null mutant KH44-91 are significantly reduced compared with wild-type ATCC 44808 CFUs in the liver and the left kidney (marked by an asterisk).

Discussion

Upstream sequences of the MLT1 gene (Theiss et al., 2002) in C. albicans revealed the presence of a third phospholipase gene in this fungus with high amino acid homology to the other known fungal phospholipases B/lysophospholipases. Two additional putative lysophospholipase genes were identified in a TnBLAST survey of the C. albicans genome sequence. Therefore, in contrast to three phosholipase B genes in non-pathogenic S. cerevisiae and D. hansenii, C. albicans harbors a gene family of five members encoding these enzymes.

Our real-time PCR analysis of CaPLB expression in Lee's medium revealed that all CaPLB genes are up-regulated in conditions favoring filamentous growth, i.e. pseudohyphae and hyphae formation at elevated temperature (37°C) and pH 4.5 and 6.8, respectively. Moreover, CaPLB gene expression levels were increased in stationary phase. In fact, using Northern or DNA microarray hybridization CaPLB1, CaPLB2 and CaPLB3 transcripts were only detectable during later stages of growth (late logarithmic or stationary phases). Interestingly, the highest expression levels of CaPLBs in our study were reached in stationary phase at the physiologically relevant temperature of 37°C and an acidic pH of 4.5 which is similar to the vaginal pH in humans. Involvement of gene regulation for filamentous growth in CaPLB gene expression has been shown in recent studies, for example, CaPLB1 is derepressed in null mutants of the repressor CaTUP1 (Hoover et al., 1998; Kadosh and Johnson, 2005). CaSsn6, another regulator of cell morphology appears to exert control on CaPLB3 gene expression since this phospholipase gene is up-regulated in cassn6 mutants (Garcia-Sanchez et al., 2005). The role of other transcription factors in CaPLB gene expression remains to be elucidated. A recent study on the influence of environmental factors like pH and carbohydrate source on in vitro expression of CaPLB1 revealed a complex pattern of expression in rich media and chemically defined media supplemented with serum or phospholipids (Mukherjee et al., 2003). Our quantitative RT-PCR study of CaPLB1 expression adds to this complexity since we identified a condition in which CaPLB1 is in fact strongly induced in chemically defined medium (Lee's medium pH 4.5, 37°C) independent of supplementation. In vivo expression has been demonstrated for CaPLB1 and CaPLB2 by RT-PCR in mice (Schofield et al., 2005) and CaPlb1 by immunological detection in host tissue (Mukherjee et al., 2001). We attempted to analyze the in vivo patterns of CaPLB5 expression using the In vivo Expression Technology (IVET) adapted to C. albicans (Staib et al., 1999), however, the high basal level activity of the CaPLB5 promoter led to considerable induction of the FLP recombinase when grown in culture, thus precluding the use of this technology without further adaptation to genes with higher basal expression levels (Bentink and Köhler; unpublished observations).

All the CaPLB genes identified in C. albicans are predicted to contain putative signal sequences by SignalP (Nielsen et al., 1997), hence the encoded hydrolytic enzymes are probably secreted under appropriate conditions. The Plbs in C. albicans with a hydrophobic COOH-terminus and a high probability for a GPI modification are CaPlb5, CaPlb3 and CaPlb4. Thus, these proteins could be localized to the plasma membrane and/or cell wall, similar to the GPI-modified CnPlb1 protein in Cr. neoformans (Djordjevic et al., 2005). Shedding of cell-associated Plbs as suggested for CnPlb1 by glucanase, protease or PI-PLC/PLD activities might also be possible in C. albicans.

The serine–rich region following the signal peptide in CaPlb5 and the putative orthologue in D. hansenii appears to be absent in phylogenetically more distant fungi. We conducted a preliminary survey of currently available genome sequences of other Candida species and found that e.g. C. dubliniensis (http://www.sanger.ac.uk/Projects/C_dubliniensis/) and C. tropicalis (http://www.broad.mit.edu/annotation/fungi/candida_tropicalis/) also harbor a CaPlb5 orthologue with an extended NH2-terminus while more distantly related C. guillermondi (http://www.broad.mit.edu/annotation/fungi/candida_guilliermondii/) and C. lusitaniae (http://www.broad.mit.edu/annotation/fungi/candida_lusitaniae/) seem to lack it. This stretch of amino acids offers a high density of possible O-glycosylation and phoshorylation sites, however, its biological role is unclear. Interestingly, two Kex2 proteinase cleavage sites are located adjacent to the COOH-terminus of this region (position 138 and 153) indicating a potential prepropeptide configuration for processing of CaPlb5. One potential cleavage site is present in the D. hansenii orthologue. Newport et al. (2003) recently conducted a survey of putative kex2 substrates in the C. albicans genome and identified several (potentially) secreted hydrolases like secreted aspartyl proteases and sphingomyelinases with Kex2 sites. CaPlb5 probably failed to be recognized by the search algorithm employed in this study, because of too restrictive search parameters. Whether CaPlb5 is indeed processed by the Kex2 proteinase or other processing enzymes remains to be elucidated.

Intrastrain heterozygosity in two amino acid residues of the two alleles present in each of the three C. albicans strains tested (ATCC 44808, CAI4 and SC5314) suggests that these exchanges might be of biological importance. CAI4 is derived from SC5314, but ATCC 44808 has a very different CARE2 hybridization pattern of genomic DNA (our unpublished observations) and therefore is likely to be only distantly related to SC5314. We are currently investigating whether the encoded allozymes are functionally different and differentially expressed in vitro or during infection. A survey of further C. albicans strains will help to judge the significance of these allelic differences and resolve whether the two amino acid substitutions are compensatory or unrelated. Differential in vivo expression of the two SAP2 alleles in CAI4 which contain two conserved amino acid exchanges and differ in pentameric repeat structures of their promoter regions, has recently been demonstrated (Staib et al., 2002).

As other similar fungal phospholipase B enzymes, CaPlb5 could be bifunctional with a lysophospholipase-transacylase activity in addition to the hydrolase activity that removes sn-1 and sn-2 fatty acids from phospholipids and lysophospholipids. Thus, CaPlb5 and other CaPlbs under different growth conditions may account for the phospholipase A activities reported in early studies on C. albicans phospholipases (reviewed in (Ghannoum, 2000)). While its range of biochemical activities and substrates still has to be determined, our findings on arachidonic acid release from PAPC by a putative phospholipase A2 activity of CaPlb5 pose an intriguing question about the functional role of this enzyme in pathogenesis. Breakdown of host cell membranes could not only lead to cell lysis, but also to the generation of bioactive lipid mediators derived from host membrane components like arachidonic acid. Hydrolysis of host phospholipids and release of free fatty acids may provide precursors for pro- or anti-inflammatory compounds, e.g. eicosanoids like prostaglandins, leukotrienes and lipoxins that might play an important role in pathogenesis (Noverr et al., 2003; Serhan, 2002).

Secreted phospholipases have been recognized as important virulence factors in microbial infections including candidiasis (Ghannoum, 2000). A CaPLB1 null mutant showed attenuated virulence in murine models of hematogenously disseminated candidiasis and oral-intragastric infection (Leidich et al., 1998; Mukherjee et al., 2001). CaPlb5 or the other additional members of the CaPlb family could account for the residual phospholipase B activity and virulence in caplb1 mutants. Cell-associated enzymes may be especially important while Candida is in close contact with host cells e.g. during invasion. However, many environmental and cell biological factors (morphology) are likely to determine the temporal and spatial expression and secretion of the different Plbs in vivo. The composition of host cell membranes could influence Plb expression in the fungi; therefore the caplb5 mutation might be more detrimental in liver than in other organs, resulting in the most significant attenuation in this organ. Ultimately, further functional characterization and in vivo expression analyses will discern the individual roles of Plb family members in candidal virulence.

Acknowledgments

This study was supported by the Bundesministerium für Bildung und Forschung (BMBF grant O1 K18906-0), by the Deutsche Forschungsgemeinschaft (grant Kr 2002/1-1) and partially by grant R21 DE014705 to G.A. Köhler. Furthermore, G.A. Köhler was recipient of a grant from the “Stipendienprogramm Infektionsforschung” of the BMBF. N. Agabian was supported by NIH grant R01 AI33317 and P01 DE016839-01. We thank William Fonzi for strain CAI4, Remo Morelli for strain SS, and Joachim Morschhäuser for pSFI1. We are also thankful to Stew Scherer for the fosmid library. Genome sequence data for Candida albicans SC5314 was generated at the Stanford DNA Sequencing and Technology Center with the support of the NICDR, the NIH and the Burroughs Wellcome Fund.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
  2. Applied Biosystems. User Bulletin #2 ABI Prism 7700 Sequence Detection System. Applied Biosystems; Foster City, CA, USA: 2001. [Google Scholar]
  3. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. John Wiley & Sons; New York, USA: 1989. [Google Scholar]
  4. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Med Sci. 1959;37:911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  5. Braun BR, van Het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A. A human-curated annotation of the Candida albicans genome. PLoS Genet. 2005;1:e1. doi: 10.1371/journal.pgen.0010001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chaitidis P, Schewe T, Sutherland M, Kuhn H, Nigam S. 15-Lipoxygenation of phospholipids may precede the sn-2 cleavage by phospholipases A2: reaction specificities of secretory and cytosolic phospholipases A2 towards native and 15-lipoxygenated arachidonoyl phospholipids. FEBS Lett. 1998;434:437–441. doi: 10.1016/s0014-5793(98)01024-2. [DOI] [PubMed] [Google Scholar]
  7. Chen SC, Wright LC, Santangelo RT, Muller M, Moran VR, Kuchel PW, Sorrell TC. Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun. 1997;65:405–411. doi: 10.1128/iai.65.2.405-411.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chen X, Magee BB, Dawson D, Magee PT, Kumamoto CA. Chromosome 1 trisomy compromises the virulence of Candida albicans. Mol Microbiol. 2004;51:551–565. doi: 10.1046/j.1365-2958.2003.03852.x. [DOI] [PubMed] [Google Scholar]
  9. Csank C, Schroppel K, Leberer E, Harcus D, Mohamed O, Meloche S, Thomas DY, Whiteway M. Roles of the Candida albicans mitogen-activated protein kinase homolog, Cek1p, in hyphal development and systemic candidiasis. Infect Immun. 1998;66:2713–2721. doi: 10.1128/iai.66.6.2713-2721.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. De Groot PW, Hellingwerf KJ, Klis FM. Genome-wide identification of fungal GPI proteins. Yeast. 2003;20:781–796. doi: 10.1002/yea.1007. [DOI] [PubMed] [Google Scholar]
  11. Diezmann S, Cox CJ, Schonian G, Vilgalys RJ, Mitchell TG. Phylogeny and evolution of medical species of Candida and related taxa: a multigenic analysis. J Clin Microbiol. 2004;42:5624–5635. doi: 10.1128/JCM.42.12.5624-5635.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Djordjevic JT, Del Poeta M, Sorrell TC, Turner KM, Wright LC. Secretion of cryptococcal phospholipase B1 (PLB1) is regulated by a glycosylphosphatidylinositol (GPI) anchor. Biochem J. 2005;389:803–812. doi: 10.1042/BJ20050063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Dolganov GM, Woodruff PG, Novikov AA, Zhang Y, Ferrando RE, Szubin R, Fahy JV. A novel method of gene transcript profiling in airway biopsy homogenates reveals increased expression of a Na+-K+-Cl- cotransporter (NKCC1) in asthmatic subjects. Genome Res. 2001;11:1473–1483. doi: 10.1101/gr.191301. [DOI] [PubMed] [Google Scholar]
  14. Dujon B, Sherman D, Fischer G, Durrens P, Casaregola S, Lafontaine I, De Montigny J, Marck C, Neuveglise C, Talla E, Goffard N, Frangeul L, Aigle M, Anthouard V, Babour A, Barbe V, Barnay S, Blanchin S, Beckerich JM, Beyne E, Bleykasten C, Boisrame A, Boyer J, Cattolico L, Confanioleri F, De Daruvar A, Despons L, Fabre E, Fairhead C, Ferry-Dumazet H, Groppi A, Hantraye F, Hennequin C, Jauniaux N, Joyet P, Kachouri R, Kerrest A, Koszul R, Lemaire M, Lesur I, Ma L, Muller H, Nicaud JM, Nikolski M, Oztas S, Ozier-Kalogeropoulos O, Pellenz S, Potier S, Richard GF, Straub ML, Suleau A, Swennen D, Tekaia F, Wesolowski-Louvel M, Westhof E, Wirth B, Zeniou-Meyer M, Zivanovic I, Bolotin-Fukuhara M, Thierry A, Bouchier C, Caudron B, Scarpelli C, Gaillardin C, Weissenbach J, Wincker P, Souciet JL. Genome evolution in yeasts. Nature. 2004;430:35–44. doi: 10.1038/nature02579. [DOI] [PubMed] [Google Scholar]
  15. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239–244. doi: 10.1086/520192. [DOI] [PubMed] [Google Scholar]
  16. Eisenhaber B, Schneider G, Wildpaner M, Eisenhaber F. A sensitive predictor for potential GPI lipid modification sites in fungal protein sequences and its application to genome-wide studies for Aspergillus nidulans, Candida albicans, Neurospora crassa, Saccharomyces cerevisiae and Schizosaccharomyces pombe. J Mol Biol. 2004;337:243–253. doi: 10.1016/j.jmb.2004.01.025. [DOI] [PubMed] [Google Scholar]
  17. Fonzi WA, Irwin MY. Isogenic strain construction and gene mapping in Candida albicans. Genetics. 1993;134:717–728. doi: 10.1093/genetics/134.3.717. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Garcia MG, O'Connor JE, Garcia LL, Martinez SI, Herrero E, del Castillo Agudo L. Isolation of a Candida albicans gene, tightly linked to URA3, coding for a putative transcription factor that suppresses a Saccharomyces cerevisiae aft1 mutation. Yeast. 2001;18:301–311. doi: 10.1002/1097-0061(20010315)18:4<301::AID-YEA672>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  19. Garcia-Sanchez S, Mavor AL, Russell CL, Argimon S, Dennison P, Enjalbert B, Brown AJ. Global roles of Ssn6 in Tup1- and Nrg1-dependent gene regulation in the fungal pathogen, Candida albicans. Mol Biol Cell. 2005;16:2913–2925. doi: 10.1091/mbc.E05-01-0071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev. 2000;13:122–143. doi: 10.1128/cmr.13.1.122-143.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gillum AM, Tsay EY, Kirsch DR. Isolation of the Candida albicans gene for orotidine-5′-phosphate decarboxylase by complementation of S. cerevisiae ura3 and E. coli pyrF mutations. Mol Gen Genet. 1984;198:179–182. doi: 10.1007/BF00328721. [DOI] [PubMed] [Google Scholar]
  22. Hoover CI, Jantapour MJ, Newport G, Agabian N, Fisher SJ. Cloning and regulated expression of the Candida albicans phospholipase B (PLB1) gene. FEMS Microbiol Lett. 1998;167:163–169. doi: 10.1111/j.1574-6968.1998.tb13223.x. [DOI] [PubMed] [Google Scholar]
  23. Ibrahim AS, Mirbod F, Filler SG, Banno Y, Cole GT, Kitajima Y, Edwards JE, Jr, Nozawa Y, Ghannoum MA. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun. 1995;63:1993–1998. doi: 10.1128/iai.63.5.1993-1998.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Jones T, Federspiel NA, Chibana H, Dungan J, Kalman S, Magee BB, Newport G, Thorstenson YR, Agabian N, Magee PT, Davis RW, Scherer S. The diploid genome sequence of Candida albicans. Proc Natl Acad Sci USA. 2004;101:7329–7334. doi: 10.1073/pnas.0401648101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kadosh D, Johnson AD. Induction of the Candida albicans filamentous growth program by relief of transcriptional repression: a genome-wide analysis. Mol Biol Cell. 2005;16:2903–2912. doi: 10.1091/mbc.E05-01-0073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Köhler GA, White TC, Agabian N. Overexpression of a cloned IMP dehydrogenase gene of Candida albicans confers resistance to the specific inhibitor mycophenolic acid. J Bacteriol. 1997;179:2331–2338. doi: 10.1128/jb.179.7.2331-2338.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee KL, Buckley HR, Campbell CC. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida albicans. Sabouraudia. 1975;13:148–153. doi: 10.1080/00362177585190271. [DOI] [PubMed] [Google Scholar]
  28. Lee KS, Patton JL, Fido M, Hines LK, Kohlwein SD, Paltauf F, Henry SA, Levin DE. The Saccharomyces cerevisiae PLB1 gene encodes a protein required for lysophospholipase and phospholipase B activity. J Biol Chem. 1994;269:19725–19730. [PubMed] [Google Scholar]
  29. Lee SA, Wormsley S, Kamoun S, Lee AF, Joiner K, Wong B. An analysis of the Candida albicans genome database for soluble secreted proteins using computer-based prediction algorithms. Yeast. 2003;20:595–610. doi: 10.1002/yea.988. [DOI] [PubMed] [Google Scholar]
  30. Leidich SD, Ibrahim AS, Fu Y, Koul A, Jessup C, Vitullo J, Fonzi W, Mirbod F, Nakashima S, Nozawa Y, Ghannoum MA. Cloning and disruption of caPLB1, a phospholipase B gene involved in the pathogenicity of Candida albicans. J Biol Chem. 1998;273:26078–26086. doi: 10.1074/jbc.273.40.26078. [DOI] [PubMed] [Google Scholar]
  31. Manning M, Mitchell TG. Strain variation and morphogenesis of yeast- and mycelial-phase Candida albicans in low-sulfate, synthetic medium. J Bacteriol. 1980;142:714–719. doi: 10.1128/jb.142.2.714-719.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Masuda N, Kitamura N, Saito K. Primary structure of protein moiety of Penicillium notatum phospholipase B deduced from the cDNA. Eur J Biochem. 1991;202:783–787. doi: 10.1111/j.1432-1033.1991.tb16433.x. [DOI] [PubMed] [Google Scholar]
  33. Merkel O, Fido M, Mayr JA, Pruger H, Raab F, Zandonella G, Kohlwein SD, Paltauf F. Characterization and function in vivo of two novel phospholipases B/lysophospholipases from Saccharomyces cerevisiae. J Biol Chem. 1999;274:28121–28127. doi: 10.1074/jbc.274.40.28121. [DOI] [PubMed] [Google Scholar]
  34. Millon L, Manteaux A, Reboux G, Drobacheff C, Monod M, Barale T, Michel-Briand Y. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol. 1994;32:1115–1118. doi: 10.1128/jcm.32.4.1115-1118.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mirbod F, Banno Y, Ghannoum MA, Ibrahim AS, Nakashima S, Kitajima Y, Cole GT, Nozawa Y. Purification and characterization of lysophospholipase-transacylase (h-LPTA) from a highly virulent strain of Candida albicans. Biochim Biophys Acta. 1995;13:181–188. doi: 10.1016/0005-2760(95)00072-k. [DOI] [PubMed] [Google Scholar]
  36. Miyasaki SH, White TC, Agabian N. A fourth secreted aspartyl proteinase gene (SAP4) and a CARE2 repetitive element are located upstream of the SAP1 gene in Candida albicans. J Bacteriol. 1994;176:1702–1710. doi: 10.1128/jb.176.6.1702-1710.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Morschhäuser J, Staib P, Köhler G. Targeted gene deletion in Candida albicans wild-type strains by MPAR flipping. Methods Mol Med. 2005;118:35–44. doi: 10.1385/1-59259-943-5:035. [DOI] [PubMed] [Google Scholar]
  38. Mukherjee PK, Seshan KR, Leidich SD, Chandra J, Cole GT, Ghannoum MA. Reintroduction of the PLB1 gene into Candida albicans restores virulence in vivo. Microbiology. 2001;147:2585–2597. doi: 10.1099/00221287-147-9-2585. [DOI] [PubMed] [Google Scholar]
  39. Mukherjee PK, Chandra J, Kuhn DM, Ghannoum MA. Differential expression of Candida albicans phospholipase B (PLB1) under various environmental and physiological conditions. Microbiology. 2003;149:261–267. doi: 10.1099/mic.0.25829-0. [DOI] [PubMed] [Google Scholar]
  40. Newport G, Kuo A, Flattery A, Gill C, Blake JJ, Kurtz MB, Abruzzo GK, Agabian N. Inactivation of Kex2p diminishes the virulence of Candida albicans. J Biol Chem. 2003;278:1713–1720. doi: 10.1074/jbc.M209713200. [DOI] [PubMed] [Google Scholar]
  41. Nielsen H, Engelbrecht J, Brunak S, von Heijne G. Identification of prokaryotic and eukaryotic signal peptides and prediction of their cleavage sites. Protein Eng. 1997;10:1–6. doi: 10.1093/protein/10.1.1. [DOI] [PubMed] [Google Scholar]
  42. Noverr MC, Erb-Downward JR, Huffnagle GB. Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes. Clin Microbiol Rev. 2003;16:517–533. doi: 10.1128/CMR.16.3.517-533.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Odds FC. Candida and candidosis. Baillière Tindall; London, Philadelphia: 1988. [Google Scholar]
  44. Prakobphol A, Leffler H, Fisher SJ. Specific adherence of Candida tropicalis to lysophospholipids. Biochemistry. 1994;33:9496–9503. doi: 10.1021/bi00198a015. [DOI] [PubMed] [Google Scholar]
  45. Prakobphol A, Leffler H, Hoover CI, Fisher SJ. Palmitoyl carnitine, a lysophospholipase-transacylase inhibitor, prevents Candida adherence in vitro. FEMS Microbiol Lett. 1997;151:89–94. doi: 10.1016/s0378-1097(97)00146-8. [DOI] [PubMed] [Google Scholar]
  46. Saito K, Sugatani J, Okumura T. Phospholipase B from Penicillium notatum. Methods Enzymol. 1991;197:446–456. doi: 10.1016/0076-6879(91)97170-4. [DOI] [PubMed] [Google Scholar]
  47. Schmiel DH, Miller VL. Bacterial phospholipases and pathogenesis. Microbes Infect. 1999;1:1103–1112. doi: 10.1016/s1286-4579(99)00205-1. [DOI] [PubMed] [Google Scholar]
  48. Schofield DA, Westwater C, Warner T, Balish E. Differential Candida albicans lipase gene expression during alimentary tract colonization and infection. FEMS Microbiol Lett. 2005;244:359–365. doi: 10.1016/j.femsle.2005.02.015. [DOI] [PubMed] [Google Scholar]
  49. Serhan CN. Lipoxins and aspirin-triggered 15-epi-lipoxin biosynthesis: an update and role in anti-inflammation and pro-resolution. Prostaglandins Other Lipid Mediat. 2002;69:433–455. doi: 10.1016/s0090-6980(02)00047-3. [DOI] [PubMed] [Google Scholar]
  50. Songer JG. Bacterial phospholipases and their role in virulence. Trends Microbiol. 1997;5:156–161. doi: 10.1016/S0966-842X(97)01005-6. [DOI] [PubMed] [Google Scholar]
  51. Staib P, Kretschmar M, Nichterlein T, Köhler G, Michel S, Hof H, Hacker J, Morschhäuser J. Host-induced, stage-specific virulence gene activation in Candida albicans during infection. Mol Microbiol. 1999;32:533–546. doi: 10.1046/j.1365-2958.1999.01367.x. [DOI] [PubMed] [Google Scholar]
  52. Staib P, Kretschmar M, Nichterlein T, Hof H, Morschhäuser J. Host versus in vitro signals and intrastrain allelic differences in the expression of a Candida albicans virulence gene. Mol Microbiol. 2002;44:1351–1366. doi: 10.1046/j.1365-2958.2002.02967.x. [DOI] [PubMed] [Google Scholar]
  53. Sugiyama Y, Nakashima S, Mirbod F, Kanoh H, Kitajima Y, Ghannoum MA, Nozawa Y. Molecular cloning of a second phospholipase B gene, caPLB2 from Candida albicans. Med Mycol. 1999;37:61–67. [PubMed] [Google Scholar]
  54. Theiss S, Kretschmar M, Nichterlein T, Hof H, Agabian N, Hacker J, Köhler GA. Functional analysis of a vacuolar ABC transporter in wild-type Candida albicans reveals its involvement in virulence. Mol Microbiol. 2002;43:571–584. doi: 10.1046/j.1365-2958.2002.02769.x. [DOI] [PubMed] [Google Scholar]
  55. Titball RW. Bacterial phospholipases C. Microbiol Rev. 1993;57:347–366. doi: 10.1128/mr.57.2.347-366.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Wirsching S, Michel S, Morschhäuser J. Targeted gene disruption in Candida albicans wild-type strains: the role of the MDR1 gene in fluconazole resistance of clinical Candida albicans isolates. Mol Microbiol. 2000;36:856–865. doi: 10.1046/j.1365-2958.2000.01899.x. [DOI] [PubMed] [Google Scholar]
  57. Witt W, Mertsching A, Konig E. Secretion of phospholipase B from Saccharomyces cerevisiae. Biochim Biophys Acta. 1984;795:117–124. doi: 10.1016/0005-2760(84)90111-5. [DOI] [PubMed] [Google Scholar]

RESOURCES